Basic Information
Opteev Technologies, Inc. was founded in 2020 as a subsidiary of Novatec. The company has developed ViraWarn, a personal, pocket-sized handheld breathalyzer device that uses patent-pending artificial intelligence (AI) and proprietary algorithms to detect COVID-19 and other respiratory viruses, including respiratory syncytial virus and influenza. ViraWarn is currently undergoing clinical trials and has not yet been approved by the U.S. Food and Drug Administration.
Opteev Technologies, Inc.
Baltimore,Maryland,United States of America
unclear
January 01, 2020
info@opteev.com
